Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: Implications for HIV-based gene transfer systems

Virology

Volumn 241, Issue 2, 1998, Pages 224-233

  Luo, Tianci ^a   Douglas, Janet L ^a   Livingston, Robyn L ^a   Garcia, J Victor ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ARTICLE; CELL STRAIN HT29; CONTROLLED STUDY; GENE TRANSFER; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS GENE; VIRUS INFECTIVITY; VIRUS PARTICLE;

AMPHOTROPIC MURINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0032520144     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8966     Document Type: Article

References (68)

1. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71:1997;5871-5877.
2. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76:1994;853-864.
3. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:1995;5048-5056.
4. Akkina R., Walton R. M., Chen M. L., Li Q-X., Planelles V., Chen I. S. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70:1996;2581-2585.
5. Aldrovandi G. M., Zack J. A. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70:1996;1505-1511.
6. Allan J. S., Coligan J. E., Lee T. H., McLane M. F., Kanki P. J., Groopman J. E., Essex M. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science. 230:1985;810-813.
7. Anderson S. J., Lenburg M., Landau N. R., Garcia J. V. The cytoplasmic domain of CD4 is sufficient for its downregulation from the cell surface by human immunodeficiency virus type 1 Nef. J. Virol. 68:1994;3092-3101.
8. Anderson S. J., Shugars D. C., Swanstrom R., Garcia J. V. Nef from primary isolates of human immunodeficiency virus type 1 suppress surface CD4 expression in human and mouse T cells. J. Virol. 67:1993;4923-4931.
9. Bandres J. C., Luria S., Ratner L. Regulation of human immunodeficiency virus Nef protein by phosphorylation. Virology. 201:1994;157-161.
10. 2. J. Virol. 70:1996;2324-2331.
11. Bates P. Chemokine receptors and HIV-1: An attractive pair? Cell. 86:1996;1-3.
12. Baur A. S., Sawai E. T., Dazin P., Fantl W. J., Cheng-Mayer C., Peterlin B. M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity. 1:1994;373-384.
13. Benson R. E., Sanfridson A., Ottinger J. S., Doyle C., Cullen B. R. Downregulation of cell surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177:1993;1561-1566.
14. Bukrinskaya A. G., Ghorpade A., Henzinger N. K., Smithgall T. E., Lewis R. E., Stevenson M. Phosphorylation-dependent human immunodeficiency virus infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA. 93:1996;367-371.
15. Carroll R., Lin J-T., Dacquel E. J., Mosca J. D., Burke D. S., St. Louis D. C. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J. Virol. 68:1994;6047-6051.
16. Chen B. K., Gandhi R. T., Baltimore D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities ofvpu, env,nef. J. Virol. 70:1996;6044-6053.
17. Coffin J. M. Retroviridae: The viruses and their replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia-New York. p. 1767-1847.
18. Colombini S., Arya S. K., Reitz M. S., Jagodzinski L., Beaver B., Wong-Staal F. Structure of simian immunodeficiency virus regulatory gene. Proc. Natl. Acad. Sci. USA. 86:1989;4813-4817.
19. Corbeau P., Kraus G., Wong-Staal F. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc. Natl. Acad. Sci. USA. 93:1996;14070-14075.
20. Cullen B. R. The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology. 205:1994;1-6.
21. Dalgleish A. G., Beverly P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London). 312:1984;763-767.
22. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
23. Fauci A. S. Pathogenesis of human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science. 239:1988;617-622.
24. open. Virology. 201:1994;373-379.
25. Garcia J. V., Miller A. D. Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef. Nature (London). 350:1991;508-511.
26. Goldsmith M. A., Warmerdam M. T., Atchison R. E., Miller M. D., Green W. C. Dissociation of the CD4 downregulation and virus infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69:1995;4112-4121.
27. Guy B., Kieny M. P., Riviere Y., Peuch C. L., Dott K., Girard M., Montagnier L., Lecocq J. P. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (London). 330:1987;266-269.
28. Iafrate A. J., Bronson S., Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16:1997;673-684.
29. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B. M., Gao L., Bloch L. M., Chen I. S. Y., Zack J. A. Requirement of human immunodeficiency virus type 1nefin vivo. J. Virol. 68:1994;3478-3485.
30. Kannagi M., Yetz J. M., Letvin N. L. In vitro growth characteristics of simian T-lymphotropic virus type III. Proc. Natl. Acad. Sci. USA. 82:1985;7053-7057.
31. Kestler H. W. III, Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of thenef. Cell. 65:1991;651-662.
32. Kim S., Byrn R., Groopman J., Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J. Virol. 63:1989;3708-3713.
33. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:1992;2232-2239.
34. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:1995;228-232.
35. Klatzman D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J. C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London). 312:1984;767-768.
36. Klotman M. E., Kim S., Buchbinder A., Derossi A., Baltimore D., Wong-Staal F. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA. 88:1991;5011-5015.
37. Landau N. R., Page K. A., Littman D. R. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65:1991;162-169.
38. Landau N. R., Warton M., Littman D. R. The envelope glycoprotein of human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature (London). 334:1988;159-162.
39. Lewis P., Hensel M., Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:1992;3053-3058.
40. Lu X., Wu X., Plemenitas A., Yu H., Sawai E. T., Abo A., Peterlin B. M. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6:1996;1677-1684.
41. Luciw P. A. Human immunodeficiency viruses and their replication. Fields Virology. 1996;Lippincott-Raven, Publishers, Philadelphia-New York. p. 1881-1952.
42. Luo T., Anderson S. J., Garcia J. V. Inhibition of Nef- and phorbol ester- induced CD4 degradation by macrolide antibiotics. J. Virol. 70:1996;1527-1534.
43. Luo T., Garcia J. V. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity is viral isolate dependent. J. Virol. 70:1996;6493-6496.
44. Luo T., Downing J. R., Garcia J. V. Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate. J. Virol. 71:1997;2535-2539.
45. Maddon P. J., Dalgleish A. G., Mcdougal J. S., Clapham P. R., Weiss R. A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:1986;333-348.
46. Mariani R., Skowronski J. CD4 downregulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc. Natl. Acad. Sci. USA. 90:1993;5549-5553.
47. Matlin K., Reggio H., Helenius A., Simons K. The pathway of vesicular stomatitis entry leading to infection. J. Mol. Biol. 156:1982;609-631.
48. Miller M. D., Warmerdam M. T., Gaston I., Green W. C., Feinberg M. B. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-113.
49. Munis J. R., Kornbluth R. S., Guatelli J. C., Richman D. D. Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages. J. Gen. Virol. 73:1992;1899-1906.
50. Naldini L., Blomer U., Gallay P., Ory D., Mulligan C., Gage F. H., Verma I. M. and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
51. Page K. A., Landau N. R., Littman D. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:1990;5270-5276.
52. Parolin C., Taddeo B., Palu G., Sodroski J. Use ofcistrans. Virology. 222:1996;415-422.
53. Poznansky M., Lever A., Bergeron L., Haseltine W., Sodroski J. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65:1991;532-536.
54. Reiser J., Harmison G., Kluepfel-Stahl S., Brady R. O., Karlsson S., Schubert M. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. 93:1996;15266-15271.
55. Rhee S. S., Marsh J. W. Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 68:1994;5156-5163.
56. Robert-Guroff M., Popovic M., Gartner S., Markham P., Gallo R. C., Reitz M. S. Structure and expression oftat-, rev-,nef. J. Virol. 64:1990;3391-3398.
57. Sanchez-Pescador R., Power M. D., Barr P. J., Steimer K. S., Stempien M. M., Brown-Shimer S. L., Gee W. W., Renard A., Randolph A., Levy J. A., Dina D., Luciw P. A. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science. 227:1985;484-492.
58. Schwartz O., Marechal V., Donos O., Heard J. M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cells. J. Virol. 69:1995;4053-4059.
59. Schwartz O., Marechal V., Gall S. L., Lemonnier F., Heard J. M. Endocytosis of MHC-1 molecules is induced by HIV-1 Nef. Nature Med. 2:1996;338-342.
60. AGM. J. Virol. 64:1990;742-747.
61. Shimada T., Fujii H., Mitsuya H., Nienhuis A. W. Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 88:1991;1043-1047.
62. Spina C. A., Guatelli J. C., Richman D. D. Establishment of a stable. inducible form of human immunodeficiency virus type 1 DNA in quiescent CD+ lymphocytes in vitro. J. Virol. 69:1995;2977-2988.
63. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C., Richman D. D. The importance of Nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179:1994;115-123.
64. Stevenson M. Portals of entry: Uncovering HIV nuclear transport pathways. Trends Cell Biol. 6:1996;9-15.
65. Trono D. HIV accessory proteins: Leading roles for the supporting cast. Cell. 82:1995;189-192.
66. Von Schwedler U., Kornbluth R. S., Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA. 91:1994;6992-6996.
67. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell. 40:1985;9-17.
68. Weinberg J. B., Mattews T. J., Cullen B. R., Malim H. Productive human immunodeficiency virus type 1 infection of nonproliferating human monocytes. J. Exp. Med. 174:1991;1477-1482.